{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:15:55Z","timestamp":1788794155080,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ejps.2008.07.003","type":"journal-article","created":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T00:40:38Z","timestamp":1216255238000},"page":"211-218","source":"Crossref","is-referenced-by-count":70,"title":["Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: The influence of polysorbate 60 and 80"],"prefix":"10.1016","volume":"35","author":[{"given":"Marianne L.","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2008.07.003_bib1","first-page":"G386","article-title":"A comparison of absorption of glycerol tristearate and glycerol trioleate by rat small intestine","volume":"259","author":"Bergstedt","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejps.2008.07.003_bib2","first-page":"147","article-title":"Biochemical and ultrastructural study of actidione\u2013cycloheximide effect on fat intestinal absorption in the rat (author's transl.)","volume":"76","author":"Bernard","year":"1980","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.ejps.2008.07.003_bib3","doi-asserted-by":"crossref","first-page":"25879","DOI":"10.1016\/S0021-9258(18)47328-0","article-title":"Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells","volume":"269","author":"Bor\u00e9n","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2008.07.003_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V","article-title":"Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats","volume":"89","author":"Caliph","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-5173(86)90050-5","article-title":"Effect of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT","volume":"33","author":"Charman","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2008.07.003_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5173(86)90049-9","article-title":"An experimental system designed to study the in situ intestinal lymphatic transport of lipophilic drugs in anesthetized rats","volume":"33","author":"Charman","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2008.07.003_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0378-5173(86)90051-7","article-title":"Testing potential dosage form strategies for intestinal lymphatic drug transport: studies in the rat","volume":"33","author":"Charman","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2008.07.003_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2004.12.006","article-title":"Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs","volume":"24","author":"Dahan","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-2275(20)38423-6","article-title":"Regulation of triglyceride-rich lipoprotein secretion by fatty acids in CaCo-2 cells","volume":"29","author":"Field","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2008.07.003_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/js970300n","article-title":"Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor","volume":"87","author":"Hauss","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0928-0987(01)00186-5","article-title":"Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats","volume":"14","author":"Holm","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib12","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1023\/A:1020311127328","article-title":"Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats","volume":"19","author":"Holm","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2008.07.003_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0731-7085(95)01256-K","article-title":"A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions","volume":"13","author":"Humberstone","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2008.07.003_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1023\/B:PHAM.0000036915.03725.19","article-title":"Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats","volume":"21","author":"Karpf","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2008.07.003_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejps.2007.08.002","article-title":"Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: Assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms","volume":"32","author":"Lind","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0928-0987(02)00051-9","article-title":"Lipid-based formulations for intestinal lymphatic delivery","volume":"15","author":"O\u2019Driscoll","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(01)00151-X","article-title":"Intestinal lymphatic drug transport: an update","volume":"50","author":"Porter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2008.07.003_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/js950221g","article-title":"Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion","volume":"85","author":"Porter","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/js9502229","article-title":"Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion","volume":"85","author":"Porter","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2008.07.003_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.07.003_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.147.3662.1149","article-title":"Protein synthesis inhibition: mechanism for the production of impaired fat absorption","volume":"147","author":"Sabesin","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.ejps.2008.07.003_bib23","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s11095-004-7684-4","article-title":"Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model","volume":"21","author":"Seeballuck","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2008.07.003_bib24","first-page":"G326","article-title":"Comparison of vitamin D and 25-hydroxyvitamin D absorption in the rat","volume":"242","author":"Sitrin","year":"1982","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejps.2008.07.003_bib25","first-page":"G715","article-title":"Formation and transport of chylomicrons by enterocytes to the lymphatics","volume":"250","author":"Tso","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejps.2008.07.003_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0021-9150(95)05712-9","article-title":"Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells","volume":"121","author":"van Greevenbroek","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejps.2008.07.003_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0021-9150(99)00289-0","article-title":"Caco-2 cells secrete two independent classes of lipoproteins with distinct density: effect of the ratio of unsaturated to saturated fatty acid","volume":"149","author":"van Greevenbroek","year":"2000","journal-title":"Atherosclerosis"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708003096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708003096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T05:32:16Z","timestamp":1631511136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098708003096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0928098708003096"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2008.07.003","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}